ES2106173T5 - Virus vegetales modificados como vectores. - Google Patents
Virus vegetales modificados como vectores.Info
- Publication number
- ES2106173T5 ES2106173T5 ES92907583T ES92907583T ES2106173T5 ES 2106173 T5 ES2106173 T5 ES 2106173T5 ES 92907583 T ES92907583 T ES 92907583T ES 92907583 T ES92907583 T ES 92907583T ES 2106173 T5 ES2106173 T5 ES 2106173T5
- Authority
- ES
- Spain
- Prior art keywords
- peptide
- vectors
- modified vegetable
- viruses
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 235000013311 vegetables Nutrition 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 2
- 230000002498 deadly effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/18011—Comoviridae
- C12N2770/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32711—Rhinovirus
- C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
LA INVENCION ES RELATIVA A PARTICULAS UNIDAS DE UN VIRUS VEGETAL QUE CONTIENE UNA PEPTIDA AJENA PREDETERMINADA COMO PARTE DE LA PROTEINA DE CUBIERTA DEL VIRUS, Y UN METODO PARA SU PRODUCCION. LA PEPTIDA AJENA ES PREFERIBLEMENTE UNA PEPTIDA BIOLOGICAMENTE FUNCIONAL, LA APLICACION BIOLOGICA DE LA CUAL REQUIERE O SE MEJORA POR PRESENTACION DE LA PEPTIDA EN ASOCIACION CON UNA MOLECULA DE PARTICULA LARGA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919108386A GB9108386D0 (en) | 1991-04-19 | 1991-04-19 | Modified plant viruses as vectors |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2106173T3 ES2106173T3 (es) | 1997-11-01 |
ES2106173T5 true ES2106173T5 (es) | 2001-08-01 |
Family
ID=10693567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92907583T Expired - Lifetime ES2106173T5 (es) | 1991-04-19 | 1992-04-02 | Virus vegetales modificados como vectores. |
Country Status (16)
Country | Link |
---|---|
US (4) | US6110466A (es) |
EP (1) | EP0580635B2 (es) |
JP (1) | JP3236614B2 (es) |
AR (1) | AR248426A1 (es) |
AT (1) | ATE154635T1 (es) |
AU (1) | AU661479B2 (es) |
CA (1) | CA2108777C (es) |
DE (1) | DE69220485T3 (es) |
DK (1) | DK0580635T4 (es) |
ES (1) | ES2106173T5 (es) |
GB (1) | GB9108386D0 (es) |
GR (2) | GR3024739T3 (es) |
HU (1) | HU218010B (es) |
NZ (1) | NZ242430A (es) |
WO (1) | WO1992018618A1 (es) |
ZA (1) | ZA922604B (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7033835B1 (en) | 1988-02-26 | 2006-04-25 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
US6660500B2 (en) | 1988-02-26 | 2003-12-09 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
US5977438A (en) * | 1988-02-26 | 1999-11-02 | Biosource Technologies, Inc. | Production of peptides in plants as viral coat protein fusions |
US6846968B1 (en) | 1988-02-26 | 2005-01-25 | Large Scale Biology Corporation | Production of lysosomal enzymes in plants by transient expression |
GB9108386D0 (en) * | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
US5612487A (en) * | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
US6034298A (en) * | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
US5484719A (en) | 1991-08-26 | 1996-01-16 | Edible Vaccines, Inc. | Vaccines produced and administered through edible plants |
GB9414118D0 (en) * | 1994-07-13 | 1994-08-31 | Axis Genetics Ltd | Modified plant viruses as vectors of heterologous peptides |
AU702802B2 (en) | 1994-10-18 | 1999-03-04 | Scottish Crop Research Institute | Method of producing a chimeric protein |
AU6976296A (en) * | 1995-09-15 | 1997-04-01 | John A Howard | Expression cassettes and methods for delivery of animal vaccines |
US6042832A (en) * | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
US7393529B2 (en) | 1998-04-09 | 2008-07-01 | Idexx Laboratories, Inc. | Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
CA2329074A1 (en) * | 1998-10-30 | 2000-05-11 | Thomas Jefferson University | Production of biomedical peptides and proteins in plants using plant virus vectors |
GB9921337D0 (en) * | 1999-09-09 | 1999-11-10 | Axis Genetics Plc | Modified plant viruses |
GB9924351D0 (en) * | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
GB9924352D0 (en) * | 1999-10-14 | 1999-12-15 | Hellendoorn Koen | Methods,compositions and applications relating to the generation of novel plant viral particles |
US7135282B1 (en) * | 1999-10-14 | 2006-11-14 | The Dow Chemical Company | Viral particles with exogenous internal epitopes |
WO2002000169A2 (en) * | 2000-06-26 | 2002-01-03 | The United States Of America, As Represented By The Secretary Of Agriculture | Production of vaccines using transgenic plants |
US6800748B2 (en) | 2001-01-25 | 2004-10-05 | Large Scale Biology Corporation | Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
CA2486118A1 (en) * | 2002-06-07 | 2003-12-18 | Large Scale Biology Corporation | Flexible vaccine assembly and vaccine delivery platform |
US20040170606A1 (en) * | 2002-06-07 | 2004-09-02 | Palmer Kenneth E. | Production of peptides in plants as viral coat protein fusions |
AU2003296902A1 (en) | 2002-09-03 | 2004-05-04 | Kentucky Bioprocessing, Llc | Production of peptides in plants as viral coat protein fusions |
WO2004044161A2 (en) * | 2002-11-06 | 2004-05-27 | Fraunhofer Usa | Expression of foreign sequences in plants using trans-activation system |
US7491509B2 (en) | 2003-02-03 | 2009-02-17 | Fraunhofer Usa, Inc. | System for expression of genes in plants |
US7692063B2 (en) * | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
US7683238B2 (en) * | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
CA2547511A1 (en) * | 2003-12-01 | 2005-07-28 | Dow Global Technolgies Inc. | Recombinant icosahedral virus like particle production in pseudomonads |
ES2532609T3 (es) | 2004-02-20 | 2015-03-30 | Ibio, Inc. | Sistemas y métodos para expresión clonales en plantas |
EP3388521A1 (en) | 2004-02-27 | 2018-10-17 | Dow AgroSciences LLC | High efficiency peptide production in plant cells |
EP1732615A4 (en) * | 2004-03-25 | 2009-09-16 | Kentucky Bioproc Llc | PRODUCTION OF PEPTIDES IN PLANTS IN THE FORM OF FUSION OF VIRAL ENVELOPE PROTEINS |
WO2005091753A2 (en) * | 2004-03-25 | 2005-10-06 | Large Scale Biology Corporation | Flexible vaccine assembly and vaccine delivery platform |
US8715923B2 (en) * | 2004-07-30 | 2014-05-06 | The United States Of America, As Represented By The Secretary Of The Navy | Protein scaffolds and viral particles for detecting analytes |
WO2006093967A2 (en) * | 2005-02-28 | 2006-09-08 | The Scripps Research Institute | Compositions and methods for targeting or imaging a tissue in a vertebrate subject |
MX2007012344A (es) * | 2005-04-05 | 2007-12-13 | Pioneer Hi Bred Int | Metodos y composiciones para disenar moleculas de acido nucleico para la expresion de polipeptido en plantas usando la desviacion de codon de virus de planta. |
US20070041999A1 (en) * | 2005-06-01 | 2007-02-22 | Lada Rasochova | Production of multivalent virus like particles |
WO2007011904A2 (en) * | 2005-07-19 | 2007-01-25 | Dow Global Technologies Inc. | Recombinant flu vaccines |
EP2025762A3 (en) | 2006-01-17 | 2009-09-30 | Health Research Inc. | Heteroduplex tracking assay |
US7618815B2 (en) * | 2006-03-08 | 2009-11-17 | University Of Kentucky Research Foundation | Viral vectors useful in soybean and methods of use |
US7923823B2 (en) * | 2007-01-23 | 2011-04-12 | Infineon Technologies Ag | Semiconductor device with parylene coating |
AU2008279584A1 (en) * | 2007-04-27 | 2009-01-29 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
AU2011230619C1 (en) | 2010-03-25 | 2016-06-23 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
EP2691530B1 (en) | 2011-06-10 | 2018-03-07 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
BR112015004714A2 (pt) | 2012-09-05 | 2017-11-21 | Medicago Inc | produção de partícula semelhante a picornavírus em plantas |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
JP6789823B2 (ja) * | 2014-04-15 | 2020-11-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 両末端peg化インテグリン結合性ペプチドおよびその使用方法 |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4407956A (en) * | 1981-03-13 | 1983-10-04 | The Regents Of The University Of California | Cloned cauliflower mosaic virus DNA as a plant vehicle |
CA1192510A (en) * | 1981-05-27 | 1985-08-27 | Lawrence E. Pelcher | Rna plant virus vector or portion thereof, a method of construction thereof, and a method of producing a gene derived product therefrom |
US4593002A (en) * | 1982-01-11 | 1986-06-03 | Salk Institute Biotechnology/Industrial Associates, Inc. | Viruses with recombinant surface proteins |
US5173410A (en) | 1984-02-15 | 1992-12-22 | Lubrizol Genetics Inc. | Transfer vector |
US4885248A (en) | 1984-02-15 | 1989-12-05 | Lubrizol Genetics, Inc. | Transfer vector |
GB8421282D0 (en) * | 1984-08-22 | 1984-09-26 | Connaught Lab | Multispecific antigenic proteins |
US4722840A (en) * | 1984-09-12 | 1988-02-02 | Chiron Corporation | Hybrid particle immunogens |
CA1288073C (en) | 1985-03-07 | 1991-08-27 | Paul G. Ahlquist | Rna transformation vector |
US4956282A (en) * | 1985-07-29 | 1990-09-11 | Calgene, Inc. | Mammalian peptide expression in plant cells |
EP0221044B1 (en) * | 1985-10-25 | 1992-09-02 | Monsanto Company | Novel plant vectors |
GB8608850D0 (en) * | 1986-04-11 | 1986-05-14 | Diatech Ltd | Packaging system |
ATE108828T1 (de) * | 1987-02-09 | 1994-08-15 | Lubrizol Genetics Inc | Hybrides rns-virus. |
US5316931A (en) * | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
AU638411B2 (en) * | 1988-02-26 | 1993-07-01 | Large Scale Biology Corporation | Non-nuclear chromosomal transformation |
CA1339841C (en) * | 1988-07-15 | 1998-04-28 | Robert L. Erwing | Synthesis of stereospecific enzyme by non-chromosomal transformation a host |
US5596132A (en) * | 1990-03-12 | 1997-01-21 | Cornell Research Foundation, Inc. | Induction of resistance to virus diseases by transformation of plants with a portion of a plant virus genome involving a read-through replicase gene |
WO1991013994A1 (en) | 1990-03-13 | 1991-09-19 | Commonwealth Scientific And Industrial Research Organisation | Gene expression |
JPH05506145A (ja) | 1990-04-06 | 1993-09-16 | コモンウエルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション | 修飾ポチウイルス外被タンパク質に基づく自己ポリマー化発現系 |
AU639088B2 (en) * | 1990-04-13 | 1993-07-15 | Digital Equipment Corporation | Telecommunications network with plesiochronous transfer mode |
GB9108386D0 (en) | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
DE69232393T2 (de) | 1991-08-01 | 2002-08-29 | Large Scale Biology Corp., Vacaville | Rekombinierte virale nukleinsäure aus pflanzen |
US5437976A (en) * | 1991-08-08 | 1995-08-01 | Arizona Board Of Regents, The University Of Arizona | Multi-domain DNA ligands bound to a solid matrix for protein and nucleic acid affinity chromatography and processing of solid-phase DNA |
US5955647A (en) | 1994-02-03 | 1999-09-21 | The Scripps Research Institute | Method for using tobacco mosaic virus to overproduce peptides and proteins |
GB9414118D0 (en) * | 1994-07-13 | 1994-08-31 | Axis Genetics Ltd | Modified plant viruses as vectors of heterologous peptides |
-
1991
- 1991-04-19 GB GB919108386A patent/GB9108386D0/en active Pending
-
1992
- 1992-04-02 AU AU14479/92A patent/AU661479B2/en not_active Ceased
- 1992-04-02 CA CA002108777A patent/CA2108777C/en not_active Expired - Lifetime
- 1992-04-02 US US08/137,032 patent/US6110466A/en not_active Expired - Fee Related
- 1992-04-02 HU HU9302954A patent/HU218010B/hu not_active IP Right Cessation
- 1992-04-02 ES ES92907583T patent/ES2106173T5/es not_active Expired - Lifetime
- 1992-04-02 AT AT92907583T patent/ATE154635T1/de not_active IP Right Cessation
- 1992-04-02 EP EP92907583A patent/EP0580635B2/en not_active Expired - Lifetime
- 1992-04-02 WO PCT/GB1992/000589 patent/WO1992018618A1/en active IP Right Grant
- 1992-04-02 DK DK92907583T patent/DK0580635T4/da active
- 1992-04-02 DE DE69220485T patent/DE69220485T3/de not_active Expired - Lifetime
- 1992-04-02 JP JP50696092A patent/JP3236614B2/ja not_active Expired - Lifetime
- 1992-04-09 ZA ZA922604A patent/ZA922604B/xx unknown
- 1992-04-20 AR AR92322168A patent/AR248426A1/es active
- 1992-04-22 NZ NZ242430A patent/NZ242430A/xx not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/471,048 patent/US5874087A/en not_active Expired - Lifetime
-
1997
- 1997-09-17 GR GR970402384T patent/GR3024739T3/el unknown
-
1999
- 1999-05-05 US US09/304,967 patent/US6884623B1/en not_active Expired - Fee Related
-
2000
- 2000-05-30 US US09/580,704 patent/US7208655B1/en not_active Expired - Fee Related
-
2001
- 2001-03-05 GR GR20010400362T patent/GR3035521T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2108777A1 (en) | 1992-10-20 |
ZA922604B (en) | 1992-12-30 |
US6884623B1 (en) | 2005-04-26 |
DE69220485T3 (de) | 2001-06-07 |
JPH06506583A (ja) | 1994-07-28 |
US6110466A (en) | 2000-08-29 |
AR248426A1 (es) | 1995-08-18 |
US7208655B1 (en) | 2007-04-24 |
GB9108386D0 (en) | 1991-06-05 |
HU9302954D0 (en) | 1994-01-28 |
AU1447992A (en) | 1992-11-17 |
AU661479B2 (en) | 1995-07-27 |
CA2108777C (en) | 2000-07-18 |
EP0580635B1 (en) | 1997-06-18 |
DE69220485T2 (de) | 1997-10-09 |
HU218010B (hu) | 2000-05-28 |
NZ242430A (en) | 1993-06-25 |
US5874087A (en) | 1999-02-23 |
HUT65554A (en) | 1994-06-28 |
EP0580635B2 (en) | 2001-02-21 |
DK0580635T3 (da) | 1998-01-19 |
DE69220485D1 (de) | 1997-07-24 |
GR3035521T3 (en) | 2001-06-29 |
DK0580635T4 (da) | 2001-03-19 |
ATE154635T1 (de) | 1997-07-15 |
ES2106173T3 (es) | 1997-11-01 |
GR3024739T3 (en) | 1997-12-31 |
EP0580635A1 (en) | 1994-02-02 |
WO1992018618A1 (en) | 1992-10-29 |
JP3236614B2 (ja) | 2001-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2106173T5 (es) | Virus vegetales modificados como vectores. | |
EA202192738A1 (ru) | Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos | |
TR199902426T2 (xx) | Bitki b�ceklerinin kontrol�. | |
ATE404516T1 (de) | Reinigung von xanthophyllen aus ringelblumenextrakten mit hohem chlorophyllgehalt | |
DE50012863D1 (de) | Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften | |
DE602006007967D1 (de) | Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon | |
ES2067457T3 (es) | Celula de origen animal con una proteina antigenica introducida en ella. | |
MY190627A (en) | Anti-vegf protein compositions and methods for producing the same | |
AR099757A2 (es) | Composición alimenticia en forma de pelet estable de proteínas comprimidas, y pienso para peces que comprende dicho pelet | |
CL2008002092A1 (es) | Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas. | |
AR085167A1 (es) | Polipeptidos de porphyromonas gingivalis, metodo de tratamiento, uso, anticuerpo y kit | |
BR112021024938A2 (pt) | Anticorpos de receptor 1 de peptídeo natriurético e métodos de uso | |
BR0312521A (pt) | Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado | |
ES2098485T3 (es) | Complejo que contiene el factor de coagulacion ix. | |
WO2020123330A3 (en) | Anti-alpha-synuclein antibodies and uses thereof | |
ATE543502T1 (de) | Allomon-abstossungsmittel zur kontrolle von arachnidae | |
MX2020003672A (es) | Proteinas de fusion inmunomoduladora. | |
ATE527280T1 (de) | Fluoreszentprotein und chromoprotein | |
ES2185652T3 (es) | Oligopeptidos derivados de fragmentos de proteinas c-reactiva. | |
ES2160235T3 (es) | Material de fragancia. | |
ATE271871T1 (de) | Substanzen zur therapie von erkrankungen, die durch hochproliferierende zellen verursacht werden | |
ES2187551T3 (es) | Proteina l2 de papilomavirus modificada y vlps formadas a partir de la misma. | |
PE20190967A1 (es) | Aislados modificados de streptomyces fungicidicus y su uso | |
KR920012420A (ko) | 항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009 | |
ES2165109T3 (es) | Vacuna mejorada para la inmunizacion contra infecciones por el virus de la tbe y procedimiento para su preparacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 580635 Country of ref document: ES |